ICD-10 Specific code Y44.4: Antithrombotic drugs [platelet-aggregation inhibitors]
Specific codes in ICD-10 are unique alphanumeric designations used to identify and categorize diseases, disorders, and conditions. They consist of 3-5 characters, including both letters and numbers, that provide a high level of detail and specificity.
Translations
| Language | Translation |
|---|---|
English
|
Antithrombotic drugs [platelet-aggregation inhibitors] |
French
|
Effets indésirables des antithrombotiques [inhibiteurs de l'agrégation plaquettaire] au cours de leur usage thérapeutique |
Hierarchical position
| Level | Code | Title | |
|---|---|---|---|
| 1 | XX | External causes of morbidity and mortality | |
| 2 | Y40-Y84 | Complications of medical and surgical care | |
| 3 | Y40-Y59 | Drugs, medicaments and biological substances causing adverse effects in therapeutic use | |
| 4 | Y44 | Agents primarily affecting blood constituents | |
| 5 | Y44.4 | Antithrombotic drugs [platelet-aggregation inhibitors] |
Indicated medicines
| Active Ingredient |
|---|
|
Promethazine is a potent, long acting, antihistamine with additional anti-emetic central sedative and anti-cholinergic properties. |